The STD Diagnostics Market Share was valued at USD 91442.1 million in 2022 and is expected to grow to USD 142477.44 million by 2030 and grow at a CAGR of 5.7 % over the forecast period of 2023-2030.   

The STD diagnostics market is a rapidly growing sector within the healthcare industry. With the increasing prevalence of sexually transmitted diseases worldwide, there is a rising demand for accurate and efficient diagnostic tools and tests.

One of the key factors driving the growth of this market is the growing awareness about sexually transmitted infections (STIs) and their potential health risks. Governments, healthcare organizations, and non-profit entities are actively promoting education and awareness campaigns to encourage individuals to get tested regularly. This has led to an increased number of people seeking diagnostic services, thereby fueling market growth.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/2995

Advancements in technology have also played a significant role in shaping the STD diagnostics market. Traditional methods of testing, such as culture-based techniques, are being replaced by more sensitive and specific molecular diagnostic tests like polymerase chain reaction (PCR) and nucleic acid amplification tests (NAATs). These newer methods offer faster results with higher accuracy, enabling early detection and timely treatment.

Key Market Segmentation:

By Type

• Chlamydia testing
• Syphilis testing
• Gonorrhea testing
• Herpes Simplex Virus testing
• Human Papilloma Virus testing
• Human Immunodeficiency Virus testing
• Chancroid testing
• Others

By Location of Testing

• Laboratory Testing
  • Commercial/Private labs
  • Public Health Labs
• Point of Care (PoC) testing

By Testing Device

Devices

• Thermal Cyclers – PCR
  • Absorbance microplate reader – Enzyme-Linked Immunosorbent Assay (ELISA)
  • Differential Light Scattering machines
  • Flow Cytometers
  • Lateral Flow Readers – Immunochromatographic assays
• Others

Point of Care (PoC) Devices

• Phone chips (microfluidics + ICT)
• Portable/benchtop/rapid diagnostic kits

Key players

The major Key players are Abbott Laboratories (US),F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Quide! Corporation(US), Hologic, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands),  DiaSorin S.p.A (Italy), Grifols S.A. (Spain) and other players listed in the final report.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com/